lundi 21 septembre 2026
RechercherExplore
Via News Knowledge File

Elf Labs

organization80% conf.·synced Aug 13, 2026

IP-focused entertainment company controlling 500+ trademarks/copyrights for characters including Cinderella, Snow White, Rapunzel, Sleeping Beauty, and Peter Pan; over $15M in royalties

31
sourced metrics
0
relationships
18
stated objectives
0
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Country Licensing
30count
Trademarks Copyrights Owned
500assets
Countries Licensed
30count
⚠ sources conflictsource
Country Count
30countries
⚠ sources conflictsource
Country Expansion
30count
Country Presence
30countries
Distribution Countries
30countries
Geographic Reach
30countries
Intellectual Property
500trademarks_and_copyrights
Intellectual Property Count
500trademarks_copyrights
⚠ sources conflictsource
International Markets
30countries
Ip Assets
500trademarks_and_copyrights
Licensing Countries
30countries
⚠ sources conflictsource
Licensing Markets
30countries
Market Cap
1600USD
⚠ sources conflictsource
Market Expansion
30countries
Market Presence
30countries
Product Count
100product_lines

Stated objectives

Expand investor base through Regulation A+ offering at $0.85/share with $1,000 minimum investment to diversify portfolios into early-stage AI innovation

source
target: 0.85 per share stated

Scale AI marketing platform to help transform data chaos into actionable insights and create high-performing content with measurable ROI

source
stated

Generate measurable ROI for clients through AI-driven content creation and data analytics

source
stated

Provide investors exposure to rapidly growing AI and tech sector at ground-floor stage

source
target: 0.85 per share minimum investment of 1000 USD stated

Elf Labs scaling distribution through patented production systems, global licensing, and streaming and mobile initiatives toward public market listing

source
target: Nasdaq listing under ticker ELFS stated

Scaling distribution through patented production systems, global licensing, and streaming and mobile initiatives

source
stated

Scale distribution through patented production systems, global licensing, and streaming and mobile initiatives toward public market listing on Nasdaq

source
stated

Scaling distribution through patented production systems, global licensing, and streaming and mobile initiatives

source
stated

Scale distribution through patented production systems, global licensing, streaming and mobile initiatives toward public market transition

source
stated

Scale distribution through patented production systems, global licensing, streaming and mobile initiatives toward public market debut

source
stated
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Notre lecture des données ›
Signaux que nous suivons
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Tendances que nous surveillons ›
Là où les sources divergent
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
Nous signalons les conflits ouvertement ›
Vérifié récemment
Vérifié avec la source d'origine
4,982
faits reliés à leur source — et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,982 faits vérifiés avec la source5,299 documents sources archivés
Interrogez ces données → isubstrate.com